Atika Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-21,000
Closed -$2.94M 98
2018
Q4
$2.94M Buy
21,000
+4,000
+24% +$607K 0.87% 46
2018
Q3
$2.9M Sell
17,000
-3,000
-15% -$504K 0.52% 67
2018
Q2
$3.47M Sell
20,000
-1,500
-7% -$225K 0.67% 58
2018
Q1
$2.48M Buy
+21,500
New +$2.29M 0.85% 45
2017
Q4
Sell
-45,000
Closed -$4.14M 93
2017
Q3
$4.14M Buy
45,000
+3,000
+7% +$233K 1.19% 24
2017
Q2
$3.37M Buy
+42,000
New +$2.33M 1.18% 28

Other funds holding LOXO

Atika Capital Management's LOXO Position: Q1 2019 in Review

Atika Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 21,000 shares — an estimated $2.94M sold.

Atika Capital Management first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $4.14M in Q3 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Atika Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Atika Capital Management sold 21,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $2.94M.
  • Atika Capital Management first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • Atika Capital Management's Loxo Oncology, Inc position peaked at $4.14M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Atika Capital Management's 13F filing for Q1 2019, filed 13 May 2019.